TriangleFOR PATIENTS · SOURCE READING
Treatment of Low-Risk Neuroblastoma
Source: Neuroblastoma Treatment (PDQ®)–Patient Version, National Cancer Institute.
Source updated: October 23, 2024 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary. Independent clinical review is pending.
For information about the treatments listed below, see the Treatment Option Overview section.
Source links and citations
Treatment of newly diagnosed low-risk neuroblastoma may include:
Source links and citations
surgery followed by observation
Source links and citations
observation alone for infants younger than 6 months who have small adrenal tumors or for infants who do not have signs or symptoms of neuroblastoma
observation with biopsy for infants younger than age 1 year who have favorable histology and meet other low-risk criteria
chemotherapy with or without surgery, for children with symptoms or children whose tumor has continued to grow and cannot be removed by surgery
Source links and citations
chemotherapy, for certain patients
radiation therapy to treat tumors that are causing serious problems and do not respond quickly to chemotherapy or surgery
Source links and citations
Use our clinical trial search to find NCI-supported cancer clinical trials that are accepting patients. You can search for trials based on the type of cancer, the age of the patient, and where the trials are being done. General information about clinical trials is also available.
Source links and citations
Preserved source evidence · Independent clinical review pending · Not medical advice